X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare VENKYS (I) LIMITED with RASOYA PROTEINS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENKYS (I) LIMITED vs RASOYA PROTEINS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENKYS (I) LIMITED RASOYA PROTEINS VENKYS (I) LIMITED/
RASOYA PROTEINS
 
P/E (TTM) x 16.5 2.6 638.2% View Chart
P/BV x 5.0 0.6 859.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 VENKYS (I) LIMITED   RASOYA PROTEINS
EQUITY SHARE DATA
    VENKYS (I) LIMITED
Mar-18
RASOYA PROTEINS
Mar-16
VENKYS (I) LIMITED/
RASOYA PROTEINS
5-Yr Chart
Click to enlarge
High Rs4,5601 651,428.6%   
Low Rs1,000NA 500,000.0%   
Sales per share (Unadj.) Rs1,908.30.4 425,740.2%  
Earnings per share (Unadj.) Rs141.7-2.3 -6,215.9%  
Cash flow per share (Unadj.) Rs161.7-2.2 -7,319.1%  
Dividends per share (Unadj.) Rs8.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs511.80.3 186,179.5%  
Shares outstanding (eoy) m14.091,708.93 0.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.51.0 145.1%   
Avg P/E ratio x19.6-0.2 -9,938.7%  
P/CF ratio (eoy) x17.2-0.2 -8,440.6%  
Price / Book Value ratio x5.41.6 331.8%  
Dividend payout %5.60-   
Avg Mkt Cap Rs m39,170769 5,093.5%   
No. of employees `0005.40.1 3,675.3%   
Total wages/salary Rs m1,70759 2,918.6%   
Avg. sales/employee Rs Th5,010.85,246.6 95.5%   
Avg. wages/employee Rs Th318.2400.7 79.4%   
Avg. net profit/employee Rs Th372.2-26,690.4 -1.4%   
INCOME DATA
Net Sales Rs m26,888766 3,510.2%  
Other income Rs m2627 3,693.0%   
Total revenues Rs m27,150773 3,511.9%   
Gross profit Rs m3,887-2,917 -133.3%  
Depreciation Rs m281121 232.1%   
Interest Rs m49945 1,115.7%   
Profit before tax Rs m3,370-3,075 -109.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-928 0.0%   
Tax Rs m1,373-107 -1,286.3%   
Profit after tax Rs m1,997-3,897 -51.2%  
Gross profit margin %14.5-380.7 -3.8%  
Effective tax rate %40.73.5 1,174.0%   
Net profit margin %7.4-508.7 -1.5%  
BALANCE SHEET DATA
Current assets Rs m7,938111 7,152.9%   
Current liabilities Rs m5,9002,892 204.0%   
Net working cap to sales %7.6-363.1 -2.1%  
Current ratio x1.30 3,506.5%  
Inventory Days Days4021 195.4%  
Debtors Days Days4015 269.8%  
Net fixed assets Rs m4,7641,864 255.6%   
Share capital Rs m1411,709 8.2%   
"Free" reserves Rs m7,071-1,249 -566.1%   
Net worth Rs m7,212470 1,535.0%   
Long term debt Rs m739960 77.0%   
Total assets Rs m14,3126,249 229.0%  
Interest coverage x7.8-67.8 -11.4%   
Debt to equity ratio x0.12.0 5.0%  
Sales to assets ratio x1.90.1 1,532.6%   
Return on assets %17.4-61.6 -28.3%  
Return on equity %27.7-829.5 -3.3%  
Return on capital %48.7-276.9 -17.6%  
Exports to sales %0.25.4 4.3%   
Imports to sales %00-   
Exports (fob) Rs m6241 150.2%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6241 150.2%   
Fx outflow Rs m640 58,090.9%   
Net fx Rs m-241 -4.1%   
CASH FLOW
From Operations Rs m2,55940 6,446.3%  
From Investments Rs m-293NA 146,450.0%  
From Financial Activity Rs m-2,448-42 5,787.9%  
Net Cashflow Rs m-182-3 6,737.0%  

Share Holding

Indian Promoters % 56.1 31.7 177.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.8 0.0 -  
FIIs % 3.2 3.7 85.1%  
ADR/GDR % 0.0 26.7 -  
Free float % 31.9 37.9 84.2%  
Shareholders   20,089 4,554 441.1%  
Pledged promoter(s) holding % 0.0 41.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENKYS (I) LIMITED With:   REI AGRO LTD.  KRBL LIMITED  AVANTI FEEDS  RADICO KHAITAN  GUJ.AMB.EXP.  

Compare VENKYS (I) LIMITED With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

VENKYS (I) LIMITED 2017-18 Annual Report Analysis (Annual Result Update)

Sep 19, 2018 | Updated on Sep 19, 2018

Here's an analysis of the annual report of VENKYS (I) LIMITED for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VENKYS (I) LIMITED. Also includes updates on the valuation of VENKYS (I) LIMITED.

VENKYS (I) LIMITED 2016-17 Annual Report Analysis (Annual Result Update)

Sep 18, 2018 | Updated on Sep 18, 2018

Here's an analysis of the annual report of VENKYS (I) LIMITED for 2016-17. It includes a full income statement, balance sheet and cash flow analysis of VENKYS (I) LIMITED. Also includes updates on the valuation of VENKYS (I) LIMITED.

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

ITC: GST Cess Weighs on Cigarettes (Quarterly Results Update - Detailed)

Nov 7, 2017

Additional cess in the GST regime hurts ITC's cigarette business.

VENKYS (I) LIMITED Announces Quarterly Results (1QFY19); Net Profit Up 36.8% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, VENKYS (I) LIMITED has posted a net profit of Rs 710 m (up 36.8% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VENKYS (I) LIMITED SHARE PRICE


Sep 21, 2018 (Close)

TRACK VENKYS (I) LIMITED

  • Track your investment in VENKYS (I) LIMITED with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENKYS (I) LIMITED

VENKYS (I) LIMITED 8-QTR ANALYSIS

COMPARE VENKYS (I) LIMITED WITH

MARKET STATS